Nan Li

Nan Li

Direktor/Vorstandsmitglied bei ODYSSEY THERAPEUTICS, INC.
40 Jahre
Technology Services
Health Technology
Commercial Services

Profil

Nan Li is the founder of Dimension Management LP, founded in 2022, serving as Managing Partner.
Current jobs include Director at Fiveonefour Labs, Inc., Automata Technologies Ltd., Tamarind Bio, Inc., and Aspect Biosystems Ltd. Mr. Li is Independent Director at Odyssey Therapeutics, Inc. starting in 2025.
Mr. Li is Investor & Board Director at Inato SAS since 2019, DarwinAI Corp.
since 2018, and Octave Health Group, Inc. since 2019.
Mr. Li is Board of Director at Hatfield, Inc. since 2017.
Mr. Li is Investor & Board Observer at Recursion Pharmaceuticals, Inc. since 2016, Zymergen, Inc. since 2013, Swiftscale Biologics, Inc. since 2020, and Anagenex, Inc. since 2020.
Mr. Li is Investor at Tempo Automation, Inc. since 2015, Dyno Therapeutics, Inc. since 2018, and n8n GmbH since 2019.
Former jobs include Director at Inato, Inc., Iterative Health, Inc., Gandeeva Therapeutics, Inc., Darwin, Inc., Anagenix Ltd., LabGenius Ltd., and Dexterity, Inc. (California).
Mr. Li was Director & Investor at Dexterity, Inc. (California).
Mr. Li was Managing Director at Obvious Management Services LLC from 2015 to 2022.
Mr. Li was Investor & Board Observer at HookLogic, Inc. from 2010 to 2012, Thorley Industries LLC from 2011 to 2012, Blue River Technology, Inc. from 2013 to 2015, and Formlabs, Inc. from 2013 to 2015.
Mr. Li was Investor at HumanAPI, Inc. from 2014 to 2015 and TPR Education IP Holdings LLC from 2011 to 2012.
Mr. Li was Venture Capital Investor at Bain Capital Ventures LP from 2010 to 2012.
Mr. Li was Principal at Bain & Co., Inc. from 2008 to 2010.
Mr. Li was Investment Partner at Innovation Endeavors LLC from 2013 to 2015.
Mr. Li was Head of Product, Operations & Finance at Sandpiper Labs, Inc. from 2012 to 2013.
Mr. Li was Investor at Planet Labs, Inc. Mr. Li was Investor at Estimote, Inc. from 2013 to 2015.
Education includes undergraduate degree from the University of Michigan.

Aktive Positionen von Nan Li

UnternehmenPositionBeginn
ZYMERGEN INC. Berater 01.01.2013
RECURSION PHARMACEUTICALS, INC. Private Equity Investor 01.10.2016
ODYSSEY THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.06.2025
Gründer 01.07.2022
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Private Equity Investor 01.11.2018
Private Equity Investor 01.08.2020
Private Equity Investor 01.01.2020

Ehemalige bekannte Positionen von Nan Li

UnternehmenPositionEnde
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Nan Li im Detail an

Ausbildung von Nan Li

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

56

Beziehungen ersten Grades

34

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen34

Consumer Durables

Technology Services

Producer Manufacturing

Technology Services

Health Technology

Finance

Commercial Services

Industrial Services

Consumer Services

Finance

Technology Services

Commercial Services

Commercial Services

Technology Services

Finance

Health Technology

Technology Services

Technology Services

Commercial Services

Health Technology

Health Technology

Technology Services

Technology Services

Technology Services

Technology Services

Health Services

Technology Services

Health Technology

Technology Services

Health Technology

Technology Services

Consumer Services

Commercial Services

Finance